Development of novel cancer therapy through the targeting bromodomain protein
Project/Area Number |
23790126
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Drug development chemistry
|
Research Institution | The University of Tokyo |
Principal Investigator |
|
Project Period (FY) |
2011 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2012: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
Fiscal Year 2011: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Keywords | ゲノム創薬 / 大腸がん / 分子標的治療 / ヒストン修飾 / 発現制御 / ゲノム |
Research Abstract |
Accumulation of BRD8 is frequently observed in colorectal cancer cells. We found that this accumulation resulted from deregulation of ubiquitin-proteasome system. Genome-wide gene expression profiling of BRD8-knocked down cells unveiled association of BRD8 with cancer progression. BRD8 may be an attractive therapeutic target for colorectal cancer.
|
Report
(3 results)
Research Products
(14 results)
-
-
[Journal Article] MRG-binding protein contributes to colorectal cancer development.2011
Author(s)
Yamaguchi K, Sakai M, Kim J, Tsunesumi S, Fujii T, Ikenoue T, Yamada Y, Akiyama Y, Muto Y, Yamaguchi R, Miyano S, Nakamura Y, Furukawa Y.
-
Journal Title
Cancer Sci.
Volume: 102(8)
Pages: 1486-1492
NAID
Related Report
Peer Reviewed
-
-
[Journal Article] MRG-binding protein contributes to colorectal cancer development2011
Author(s)
Yamaguchi K, Sakai M, Kim J, Tsunesumi S, Fujii T, Ikenoue T, Yamada Y, Akiyama Y, Muto Y, Yamaguchi R, Miyano S, Nakamura Y, Furukawa Y
-
Journal Title
Cancer Sci
Volume: 102
Pages: 1486-1492
NAID
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-